Stock Market News13 hours Here’s Why You Should Retain OPKO Health Stock in Your Portfolio Zacks
OPK’s growth is fueled by Rayaldee’s success and accelerated clinical trials. However, stiff competition and overdependence on its lead product are concerns.
XOPK’s growth is fueled by Rayaldee’s success and accelerated clinical trials. However, stiff competition and overdependence on its lead product are concerns.
X